0001362118-23-000034.txt : 20230530
0001362118-23-000034.hdr.sgml : 20230530
20230530153001
ACCESSION NUMBER: 0001362118-23-000034
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230526
FILED AS OF DATE: 20230530
DATE AS OF CHANGE: 20230530
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Roberts Brad Michael
CENTRAL INDEX KEY: 0001844066
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39785
FILM NUMBER: 23975813
MAIL ADDRESS:
STREET 1: 300 CHAFFORD COURT
CITY: SIMPSONVILLE
STATE: SC
ZIP: 29681
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LifeMD, Inc.
CENTRAL INDEX KEY: 0000948320
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 760238453
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 236 FIFTH AVENUE
STREET 2: SUITE 400
CITY: NEW YORK
STATE: NY
ZIP: 10001
BUSINESS PHONE: (866) 351-5907
MAIL ADDRESS:
STREET 1: 236 FIFTH AVENUE
STREET 2: SUITE 400
CITY: NEW YORK
STATE: NY
ZIP: 10001
FORMER COMPANY:
FORMER CONFORMED NAME: CONVERSION LABS, INC.
DATE OF NAME CHANGE: 20180622
FORMER COMPANY:
FORMER CONFORMED NAME: Immudyne, Inc.
DATE OF NAME CHANGE: 20120514
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUDYNE INC
DATE OF NAME CHANGE: 19950720
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0407
4
2023-05-26
0
0000948320
LifeMD, Inc.
LFMD
0001844066
Roberts Brad Michael
C/O LIFEMD, INC.
236 FIFTH AVENUE, 4TH FLOOR
NEW YORK
NY
10001
0
1
0
0
Chief Operating Officer
0
Common Stock, par value $0.01
2023-05-26
4
P
0
30000
2.1902
A
97632
D
The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.1798 to $2.20 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
/s/ Brad Michael Roberts
2023-05-30